Skyrizi 150 MG/ML penml
Ended Awarded Last action
- Contract number
- SPE2DR26FP8MX
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $75,550
Award facts
- Contract value 100% obligated
- $75,550.26 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $75,550.26 firm fixed-price delivery order to Amerisourcebergen Drug Corp (UEI: KABZK8W6PQT3) on January 12, 2026, for the supply of SKYRIZI 150 mg/mL pen needles. The contract, which is not set-aside, will be performed at the company's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of January 13, 2026. Amerisourcebergen Drug Corp operates as a child entity under its parent company Cencora, Inc. (doing business as Amerisourcebergen), a major pharmaceutical distributor serving federal government healthcare systems. This delivery order is issued under a broader Indefinite Delivery Contract with the DLA Troop Support Medical valued at up to $999,999,999.00 through December 2026, which serves as the primary vehicle for supplying pharmaceutical products and medical supplies to support military healthcare programs globally.
This award reflects Cencora/Amerisourcebergen's established role as a critical vendor for federal medical procurement, particularly within the Defense Health Agency and military treatment facilities. The company competes on a full and open basis for such awards and maintains comprehensive pharmaceutical supply capabilities across multiple therapeutic domains. The delivery order for SKYRIZI, a biologic medication used in dermatology, demonstrates the company's capacity to fulfill specialized pharmaceutical requirements within the military healthcare supply chain on a firm fixed-price basis.
Quick answers
Who was awarded contract SPE2DR26FP8MX?
SPE2DR26FP8MX was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 12, 2026.
How much is contract SPE2DR26FP8MX worth?
The government has obligated $75,550 on SPE2DR26FP8MX.
Is contract SPE2DR26FP8MX an order under another contract?
Yes. SPE2DR26FP8MX is a delivery order under SPE2DR25D3005, an indefinite delivery contract.
Was contract SPE2DR26FP8MX competed?
The extent of competition for SPE2DR26FP8MX was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award